Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,709 public trials 1,045 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL

NCT03543813

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +29 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • California Cancer Associates for Research and Excellence Encinitas, California, United States
  • University of Southern California Los Angeles, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 25 locations
View Trial Details
Completed

Study to Determine the Effect of Food on the Blood Levels of AZD9291 Following Oral Dosing of a Tablet Formulation in Patients With Non-Small Cell Lung Cancer

NCT02163733

Conditions
Advanced (Inoperable) Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer, Bronchial Neoplasms, +9 more
Locations
  • Research Site Dijon, France
  • Research Site Lyon, France
  • Research Site Saint-Herblain, France
  • Research Site Seoul, South Korea
View all 13 locations
View Trial Details
Completed

Prospective Clinicogenomic Program

NCT04180176

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • Alabama Oncology Birmingham, Alabama, United States
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • Ironwood Cancer & Research Centers Chandler, Arizona, United States
  • Yale University New Haven, Connecticut, United States
View all 23 locations
View Trial Details
Completed

Hypofractionated Image-Guided Radiation Therapy (IGRT) in Patients With Stage II-III Non-Small Cell Lung Cancer

NCT01459497

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Georgetown Cancer Center (Austin Cancer Center) Austin, Texas, United States
  • University of Texas Southwestern Medical Center Dallas, Texas, United States
  • Md Anderson Cancer Center Houston, Texas, United States
  • Baylor Research Institute Dallas, Baylor Irving Irving, Texas, United States
View Trial Details
Completed

BIOLUMA: Biomarkers for Nivolumab and Ipilimumab and Evaluation of the Combination in Lung Cancer

NCT03083691

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • SLK-Fachklinik Löwenstein Löwenstein, Baden-Wurttemberg, Germany
  • Universitätsklinikum Tübingen, Innere Medizin VIII - Medizinische Onkologie und Pneumologie Tübingen, Baden-Wurttemberg, Germany
  • Universitätsklinikum Würzburg - Comprehensive Cancer Center Mainfranken Würzburg, Bavaria, Germany
  • Universitätsklinikum Frankfurt - Medizinische Klinik II Frankfurt am Main, Hesse, Germany
View all 16 locations
View Trial Details

Related conditions